Full-length GHRH(1-44) analog with trans-3-hexenoic acid modification. DPP-IV resistant GHRH analog for visceral adiposity, GH/IGF-1 axis, and lipodystrophy model research.
Tesamorelin (Egrifta) is a synthetic 44-amino acid GHRH analog with a trans-3-hexenoic acid N-terminal modification that confers DPP-IV resistance. It binds the pituitary GHRH receptor (GHRHR) with high affinity and stimulates pulsatile GH secretion and consequently hepatic IGF-1 production, faithfully mimicking physiological GHRH activity.
HPLC >=99%; LC-MS confirmed; LAL endotoxin <=1 EU/mg. Full CoA provided.
For Research Use Only. Not for human or veterinary use.
| Product Name | Tesamorelin |
| CAS Number | 106612-94-6 |
| Purity | ≥99% (by HPLC) |
| Molecular Weight | 4,885.45 g/mol |
| Molecular Formula | C221H361N65O63S2 |
| Appearance | White lyophilized powder |
| Storage | Store at -20C desiccated. Stable >=24 months. Reconstituted: use within 7 days at 2-8C. |
| Available Sizes | 10mg · Custom |
Store at -20C desiccated. Stable >=24 months. Reconstituted: use within 7 days at 2-8C.
24 months from manufacture when stored properly.
Cold-chain shipping with ice packs. Express delivery to 35+ countries.
Get premium research-grade peptides with complete documentation and worldwide delivery.
Tesamorelin · CAS 106612-94-6
Quote request sent! We'll respond within 24 hours.
